Theory Paper IIIDrNB Cardiology – Theory Notes

AORTIC DISSECTION CLASSIFICATION; ADVANCES IN MANAGEMENT

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IINTRODUCTION AND PATHOPHYSIOLOGY

  • Definition: A catastrophic cardiovascular emergency characterized by a tear in the aortic intima that allows pulsatile blood to track into the media, creating a true lumen and a false lumen separated by an intimal flap.
  • The Hemodynamic Driver: Propagation of the dissection tear is directly driven by dP/dt (the rate of rise of left ventricular systolic pressure / shear stress) and absolute systolic blood pressure.

IICLASSIFICATION SYSTEMS AND RISK STRATIFICATION

  • Stanford Classification (Functionally Guides Management):
    • Type A: Involves the Ascending Aorta, regardless of the anatomical site of the primary intimal tear.
    • Type B: Does not involve the Ascending Aorta (originates distal to the left subclavian artery).
    • DeBakey Classification (Anatomical Origin and Extent):
    • Type I: Originates in the ascending aorta and propagates to the aortic arch and descending aorta.
    • Type II: Confined strictly to the ascending aorta.
    • Type IIIa: Originates in the descending aorta and is confined strictly to the thoracic aorta above the diaphragm.
    • Type IIIb: Originates in the descending aorta and extends below the diaphragm into the abdominal aorta.
    • Modern ESC/AHA Classification Addition:
    • Non-A Non-B Dissection: Involves the aortic arch (either by retrograde extension from the descending aorta or an arch entry tear) while strictly sparing the ascending aorta; managed similarly to complicated Type B dissection or via hybrid arch repair.
    • Type B Clinical Risk Stratification:
    • Uncomplicated Type B: Pain resolves, blood pressure is controlled, and there is no evidence of rupture or end-organ ischemia.
    • High-Risk Uncomplicated Type B: Uncomplicated presentation but with high-risk anatomical features on CTA—such as initial false lumen diameter greater than 22 mm, primary entry tear greater than 10 mm, or partial false lumen thrombosis.
    • Complicated Type B: Characterized by refractory pain, rapid aortic expansion (greater than 5 mm), impending/contained rupture, or Malperfusion Syndrome (visceral/mesenteric, renal, spinal cord, or lower-extremity ischemia).

IIIDIAGNOSTIC ALGORITHM

  • Biochemical Markers: D-dimer is highly sensitive; a level less than 500 ng/mL helps rule out acute aortic dissection in patients with low-to-intermediate pre-test probability (Class IIa).
  • Imaging Modalities:
    • CT Angiography (CTA) of the Entire Aorta (Chest, Abdomen, Pelvis): The Class I gold standard for rapid diagnosis, tear classification, branch vessel assessment, and pre-procedural planning.
    • Transesophageal Echocardiography (TEE): Reserved strictly for hemodynamically unstable patients in the emergency room or operating theater.
    • Magnetic Resonance Angiography (MRA): Preferred for chronic long-term serial surveillance to minimize cumulative radiation and iodinated contrast exposure.

IVACUTE MEDICAL AND DEFINITIVE MANAGEMENT STRATEGIES

AAcute Medical Stabilization (Anti-Impulse Therapy — Class I)

  • Hemodynamic Targets: Rapidly reduce Heart Rate to less than 60 bpm and Systolic Blood Pressure to 100 to 120 mmHg.
  • Step 1 — Intravenous Beta-Blockade (First-Line): Administer Esmolol or Labetalol intravenously to simultaneously lower heart rate and left ventricular dP/dt (shear stress).
  • Step 2 — Intravenous Vasodilators (Second-Line Only): If systolic blood pressure remains elevated after adequate beta-blockade is achieved, add Intravenous Sodium Nitroprusside or Nicardipine.
  • Critical Clinical Rule: Never administer a pure vasodilator (such as Nitroprusside or Hydralazine) prior to beta-blockade, as it triggers reflex sympathetic tachycardia, markedly increasing dP/dt and propagating the dissection flap.

BDefinitive Surgical and Endovascular Management

Dissection Category Guideline Class Definitive Management Strategy
Stanford Type A (DeBakey I & II) Class I, LOE B Emergency Open Surgical Repair: Ascending aortic replacement, resection of primary tear, Right Axillary Artery Cannulation (antegrade cerebral perfusion), Valve-Sparing Root Replacement (David) or Bentall, and Frozen Elephant Trunk (FET) for arch/descending extension
Complicated Stanford Type B (Malperfusion / Rupture) Class I, LOE B Emergency TEVAR (Thoracic Endovascular Aortic Repair) to cover the primary entry tear, expand the true lumen, and restore branch perfusion
High-Risk Uncomplicated Type B (False lumen >22 mm, Tear >10 mm) Class IIa Pre-emptive / Subacute TEVAR plus optimal medical therapy to induce false lumen thrombosis and prevent late aneurysmal degeneration (INSTEAD-XL & ADSORB Trials)
Low-Risk Uncomplicated Type B Class I Optimal Medical Therapy (OMT) with strict anti-impulse BP control and serial CTA/MRA surveillance

VLONG-TERM MANAGEMENT AND SURVEILLANCE

  • Lifelong Blood Pressure Target: Maintain blood pressure less than 130/80 mmHg (ESC 2024; SBP below 120 mmHg in the acute phase) to minimize chronic wall stress.
  • Disease-Modifying Pharmacotherapy: Lifelong Beta-blockers combined with Angiotensin Receptor Blockers (Losartan or Irbesartan), which inhibit Transforming Growth Factor-beta (TGF-beta) signaling in the aortic media and may slow secondary aneurysmal expansion (evidence mainly from Marfan syndrome).
  • Surveillance Imaging Schedule (Class I): Perform CTA or MRA of the entire aorta at 1 month, 3 months, 6 months, 12 months, and annually thereafter for life (dedicated multidisciplinary Aortic Clinics improve compliance; expansion greater than 5 mm/year triggers re-intervention).
  • Lifestyle Restrictions: Strict avoidance of competitive contact sports, isometric exercises, and heavy weightlifting (Class IIa).

VIRECENT ADVANCES AND LANDMARK TRIALS

  • Surgical Innovations in Type A Dissection:
    • Frozen Elephant Trunk (FET): Single-stage hybrid operation combining open surgical replacement of the ascending aorta and arch with antegrade deployment of a stented endograft trunk into the descending aorta, expanding the true lumen and obliterating the proximal false lumen.
    • Valve-Sparing Aortic Root Replacement (VSRR / David Procedure): Re-suspends the native aortic valve inside a synthetic graft in young patients, avoiding lifelong anticoagulation.
    • Right Axillary Artery Cannulation: Replaces retrograde femoral cannulation during cardiopulmonary bypass, preventing retrograde atheroembolic stroke.
    • Endovascular Innovations in Type B Dissection:
    • INSTEAD-XL and ADSORB Trials: Demonstrated that adding TEVAR to medical therapy in uncomplicated Type B dissection promotes false lumen thrombosis and true lumen recovery (ADSORB, 1 year) and improved 5-year aorta-specific survival (INSTEAD-XL).
    • The FLIRT Concept (False Lumen Interventions to Promote Remodeling and Thrombosis): Uses techniques such as the “Candy-Plug” occluder or coil embolization inside a persistently perfused distal false lumen to force complete thrombosis.
    • Fenestrated and Branched TEVAR (F-TEVAR / B-TEVAR): Custom stent-grafts with fenestrations or side-branches that allow endovascular sealing across the visceral and renal arteries.
    • 18F-FDG PET-CT (“The Vulnerable Aorta”): Detects active macrophage-driven inflammation in the false lumen wall, an investigational predictor of rapid expansion.

Key references

  • Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 12th Ed., Elsevier, 2022.
  • Nienaber CA, et al. (INSTEAD-XL Trial) & Brunkwall J, et al. (ADSORB Trial): Endovascular repair vs. medical therapy in uncomplicated Type B aortic dissection.
  • Isselbacher EM, et al.: 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease, Circulation, 2022; Mazzolai L, et al.: 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases, European Heart Journal, 2024.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.